Page 3 - Tyr Pharma Company News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Tyr pharma company. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Tyr Pharma Company Today - Breaking & Trending Today

aTyr Pharma (NASDAQ:LIFE) Price Target Raised to $20.00

ATyr Pharma (NASDAQ:LIFE – Free Report) had its price target boosted by Piper Sandler from $13.00 to $20.00 in a research report released on Thursday, MarketBeat Ratings reports. The firm currently has an overweight rating on the biotechnology company’s stock. A number of other equities research analysts have also recently commented on LIFE. StockNews.com upgraded […] ....

United States , Paul Schimmel , Piper Sandler , Securities Exchange Commission , Geode Capital Management , Samsara Biocapital , Jpmorgan Chase Co , Squarepoint Ops , Atyr Pharma Inc , Tyr Pharma Company Profile , Tyr Pharma , Free Report , Marketbeat Ratings , Moderate Buy , Get Free Report , Director Paul Schimmel , Exchange Commission , Capital Management , Tyr Pharma Company , Tyr Pharma Daily , Atyr Pharma , Nasdaq Life , Boost Price Target ,

aTyr Pharma (NASDAQ:LIFE) Upgraded to Hold by StockNews.com

aTyr Pharma (NASDAQ:LIFE) Upgraded to Hold by StockNews.com
kopsource.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from kopsource.com Daily Mail and Mail on Sunday newspapers.

United States , Paul Schimmel , Piper Sandler , Boothbay Fund Management , Securities Exchange Commission , Atyr Pharma Inc , Tower Research Capital , Tyr Pharma Company Profile , Jpmorgan Chase Co , Royal Bank , Millennium Management , Tyr Pharma , Free Report , Moderate Buy , Get Free Report , Director Paul Schimmel , Exchange Commission , Fund Management , Research Capital , Tyr Pharma Company , Tyr Pharma Daily ,

aTyr Pharma, Inc. (NASDAQ:LIFE) Receives $19.00 Consensus Price Target from Analysts

Shares of aTyr Pharma, Inc. (NASDAQ:LIFE – Get Free Report) have received a consensus recommendation of “Moderate Buy” from the six ratings firms that are currently covering the firm, MarketBeat reports. One investment analyst has rated the stock with a hold rating and five have issued a buy rating on the company. The average 12 […] ....

United States , Piper Sandler , Paul Schimmel , Tyr Pharma Company Profile , Atyr Pharma Inc , Charles Schwab Investment Management Inc , Squarepoint Ops , Marshall Wace , Virtu Financial , Tyr Pharma , Get Free Report , Tyr Pharma Stock Down , Director Paul Schimmel , Street Group , Charles Schwab Investment Management , Schwab Investment Management , Tyr Pharma Company , Get Free , Tyr Pharma Daily , Atyr Pharma , Nasdaq Life ,

StockNews.com Downgrades aTyr Pharma (NASDAQ:LIFE) to Sell

StockNews.com Downgrades aTyr Pharma (NASDAQ:LIFE) to Sell
kopsource.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from kopsource.com Daily Mail and Mail on Sunday newspapers.

United States , Piper Sandler , Paul Schimmel , Charles Schwab Investment Management Inc , Virtu Financial , York Mellon Corp , Squarepoint Ops , Tyr Pharma Company Profile , Atyr Pharma Inc , Tyr Pharma , Free Report , Moderate Buy , Tyr Pharma Stock , Get Free Report , Director Paul Schimmel , Street Group , Schwab Investment Management , New York Mellon Corp , Tyr Pharma Company , Tyr Pharma Daily ,

aTyr Pharma (NASDAQ:LIFE) Downgraded by StockNews.com

ATyr Pharma (NASDAQ:LIFE – Get Free Report) was downgraded by stock analysts at StockNews.com from a “hold” rating to a “sell” rating in a note issued to investors on Tuesday. A number of other research analysts also recently issued reports on LIFE. Piper Sandler boosted their price target on aTyr Pharma from $9.00 to $13.00 […] ....

United States , Paul Schimmel , Piper Sandler , Virtu Financial , Squarepoint Ops , Tyr Pharma Company Profile , Charles Schwab Investment Management Inc , Atyr Pharma Inc , Marshall Wace , Tyr Pharma , Get Free Report , Tyr Pharma Price , Director Paul Schimmel , Street Group , Charles Schwab Investment Management , Schwab Investment Management , Tyr Pharma Company , Tyr Pharma Daily , Atyr Pharma , Nasdaq Life , Stocknews Com ,